Position in HURA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,867
+$5,845 QoQ
Shares Held
10,627
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#58
of 90 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HURA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026HANCOCK WHITNEY CORP holds $38,673,624 across 11 Biotechnology names. HURA ranks #9 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
330,756 | $17,996,433 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
205,652 | $16,096,381 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
6,649 | $1,602,209 | |
| 4 | INCY |
Incyte Corp
|
10,836 | $1,228,368 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,276 | $633,827 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
792 | $493,843 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
8,677 | $315,928 | |
| 8 | INVA |
Innoviva, Inc.
|
11,967 | $271,769 |
All Filings in HURA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,867 | 10,627 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $19,022 | 10,627 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $8,044 | 10,627 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $26,354 | 10,627 | Shares | Defined | 2025-11-17 | |
| 2025-06-30 | $23,698 | 10,627 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||